⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRSP News
CRISPR Therapeutics AG
COUR Pharma Announces Positive One-Year Results from the Phase 2a Study of CNP-104 in Primary Biliary Cholangitis
globenewswire.com
CRSP
Santhera Announces Proposed Inclusion and Reimbursement of AGAMREE® (Vamorolone) within Spain’s National Health System for the Treatment of Duchenne Muscular Dystrophy
globenewswire.com
CRSP
REGN
PTGX
Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026
prnewswire.com
BNTX
CRSP
NVCR
IBRX
ONCY
Sickle Cell Disease Competitive Landscape Report 2026: Comprehensive Analysis of Over 40 Companies and More Than 50 Drugs
globenewswire.com
NVS
PFE
AGIO
CRSP
TAK
Longevity Market Report 2026-2036: Advances in AI, Genomics and Regenerative Medicine Are Accelerating Developments
globenewswire.com
VRTX
CRSP
Watchmaker Genomics concede in licenza la proprietà intellettuale CRISPR-Cas9 da Caribou Biosciences per aumentare la produzione e ridurre il costo del sequenziamento per campione
businesswire.com
CRSP
WGO
Watchmaker Genomics concede in licenza la proprietà intellettuale CRISPR-Cas9 da Caribou Biosciences per aumentare la produzione e ridurre il costo del sequenziamento per campione
businesswire.com
CRSP
WGO
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
CAR T-Cell Therapy Market worth $13.78 billion by 2031 | MarketsandMarkets™
prnewswire.com
BMY
GILD
JNJ
CRSP
ALLO
CART